Rotavirus 2/6 Virus-Like Particles Administered Intranasally in Mice, with or without the Mucosal Adjuvants Cholera Toxin andEscherichia coliHeat-Labile Toxin, Induce a Th1/Th2-Like Immune Response
Open Access
- 15 November 2001
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 75 (22) , 11010-11016
- https://doi.org/10.1128/jvi.75.22.11010-11016.2001
Abstract
We investigated the rotavirus-specific lymphocyte responses induced by intranasal immunization of adult BALB/c mice with rotavirus 2/6 virus-like particles (2/6-VLPs) of the bovine RF strain, by assessing the profile of cytokines produced after in vitro restimulation and serum and fecal antibody responses. The cytokines produced by splenic cells were first evaluated. Intranasal immunization with 50 μg of 2/6-VLPs induced a high serum antibody response, including immunoglobulin G1 (IgG1) and IgG2a, a weak fecal antibody response, and a mixed Th1/Th2-like profile of cytokines characterized by gamma interferon and interleukin 10 (IL-10) production and very low levels of IL-2, IL-4, and IL-5. Intranasal immunization with 10 μg of 2/6-VLPs coadministered with the mucosal adjuvants cholera toxin andEscherichia coli heat-labile toxin (LT) considerably enhanced the Th1/Th2-like response; notably, significant levels of IL-2, IL-4, and IL-5 were observed. Since rotavirus is an enteric pathogen, we next investigated the production of IL-2 and IL-5, as being representative of Th1 and Th2 responses, by Peyer's patch and mesenteric lymph node cells from mice immunized intranasally with 2/6-VLPs and LT. The results were compared to those obtained from splenic and cervical lymph node cells. We found that both cytokines were produced by cells from each of these lymphoid tissues. These results confirm the Th1/Th2-like response observed at the systemic level and show, on the assumption that T cells are the primary cells producing the cytokines after in vitro restimulation, that rotavirus-specific T lymphocytes are present in the intestine after intranasal immunization with 2/6-VLPs and LT.Keywords
This publication has 44 references indexed in Scilit:
- Intranasal Administration of 2/6-Rotavirus-Like Particles with MutantEscherichia coliHeat-Labile Toxin (LT-R192G) Induces Antibody-Secreting Cell Responses but Not Protective Immunity in Gnotobiotic PigsJournal of Virology, 2000
- Nasal Immunization of Mice with Virus-Like Particles Protects Offspring against Rotavirus DiarrheaJournal of Virology, 2000
- Rotavirus vaccinesCurrent Opinion in Infectious Diseases, 2000
- Intranasal Immunization withToxoplasma gondiiSAG1 Induces Protective Cells into Both NALT and GALT CompartmentsInfection and Immunity, 2000
- Mucosal Th1‐ versus Th2‐Type Responses for Antibody‐ or Cell‐Mediated Immunity to Simian Immunodeficiency Virus in Rhesus MacaquesThe Journal of Infectious Diseases, 1999
- Oral Delivery of Homologous and Heterologous Strains of Rotavirus to BALB/c Mice Induces the Same Profile of Cytokine Production by Spleen CellsVirology, 1998
- Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune systemImmunologic Research, 1997
- Novel intranasal immunization techniques for antibody induction and protection of mice against gastric Helicobacter felis infectionVaccine, 1997
- Mechanisms for Mucosal Immunogenicity and Adjuvancy of Escherichia coli Labile EnterotoxinThe Journal of Infectious Diseases, 1996
- Helper T cell subsets for immunoglobulin A responses: oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues.The Journal of Experimental Medicine, 1993